Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Akesobio Australia Pty Ltd
Scientific Title
A Phase 1A/1B Multicenter, Open-label, Dose-escalation, and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK105 in Subjects With Advanced Solid Tumors